Published in AIDS Weekly, December 5th, 2005
For the 9 months ended September 30, 2005, the company reported a net loss of $15.6 million, or $0.18 per share, compared to $12.0 million, or $0.15 per share for the same period in 2004. As of September 30, 2005, cash and cash equivalents were $17.2 million, compared to $34.1 million at December 31, 2004.
Revenue for the 3 months ended September 30, 2005 was $1.5 million,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.